222 related articles for article (PubMed ID: 30209650)
1. Platelet-derived extracellular vesicles in Huntington's disease.
Denis HL; Lamontagne-Proulx J; St-Amour I; Mason SL; Weiss A; Chouinard S; Barker RA; Boilard E; Cicchetti F
J Neurol; 2018 Nov; 265(11):2704-2712. PubMed ID: 30209650
[TBL] [Abstract][Full Text] [Related]
2. Portrait of blood-derived extracellular vesicles in patients with Parkinson's disease.
Lamontagne-Proulx J; St-Amour I; Labib R; Pilon J; Denis HL; Cloutier N; Roux-Dalvai F; Vincent AT; Mason SL; Williams-Gray C; Duchez AC; Droit A; Lacroix S; Dupré N; Langlois M; Chouinard S; Panisset M; Barker RA; Boilard E; Cicchetti F
Neurobiol Dis; 2019 Apr; 124():163-175. PubMed ID: 30408591
[TBL] [Abstract][Full Text] [Related]
3. Huntingtin Co-Isolates with Small Extracellular Vesicles from Blood Plasma of TgHD and KI-HD Pig Models of Huntington's Disease and Human Blood Plasma.
Ananbeh H; Novak J; Juhas S; Juhasova J; Klempir J; Doleckova K; Rysankova I; Turnovcova K; Hanus J; Hansikova H; Vodicka P; Kupcova Skalnikova H
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628406
[TBL] [Abstract][Full Text] [Related]
4. Platelet abnormalities in Huntington's disease.
Denis HL; Lamontagne-Proulx J; St-Amour I; Mason SL; Rowley JW; Cloutier N; Tremblay MÈ; Vincent AT; Gould PV; Chouinard S; Weyrich AS; Rondina MT; Barker RA; Boilard E; Cicchetti F
J Neurol Neurosurg Psychiatry; 2019 Mar; 90(3):272-283. PubMed ID: 30567722
[TBL] [Abstract][Full Text] [Related]
5. Peripheral Biomarkers in Manifest and Premanifest Huntington's Disease.
Morena E; Romano C; Marconi M; Diamant S; Buscarinu MC; Bellucci G; Romano S; Scarabino D; Salvetti M; Ristori G
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047023
[TBL] [Abstract][Full Text] [Related]
6. Liver function in Huntington's disease assessed by blood biochemical analyses in a clinical setting.
Nielsen SM; Vinther-Jensen T; Nielsen JE; Nørremølle A; Hasholt L; Hjermind LE; Josefsen K
J Neurol Sci; 2016 Mar; 362():326-32. PubMed ID: 26944172
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's disease.
Byrne LM; Rodrigues FB; Johnson EB; Wijeratne PA; De Vita E; Alexander DC; Palermo G; Czech C; Schobel S; Scahill RI; Heslegrave A; Zetterberg H; Wild EJ
Sci Transl Med; 2018 Sep; 10(458):. PubMed ID: 30209243
[TBL] [Abstract][Full Text] [Related]
8. Human-to-mouse prion-like propagation of mutant huntingtin protein.
Jeon I; Cicchetti F; Cisbani G; Lee S; Li E; Bae J; Lee N; Li L; Im W; Kim M; Kim HS; Oh SH; Kim TA; Ko JJ; Aubé B; Oueslati A; Kim YJ; Song J
Acta Neuropathol; 2016 Oct; 132(4):577-92. PubMed ID: 27221146
[TBL] [Abstract][Full Text] [Related]
9. Emerging Roles of Exosomes in Huntington's Disease.
Ananbeh H; Vodicka P; Kupcova Skalnikova H
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920936
[TBL] [Abstract][Full Text] [Related]
10. The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington disease.
Russell DS; Barret O; Jennings DL; Friedman JH; Tamagnan GD; Thomae D; Alagille D; Morley TJ; Papin C; Papapetropoulos S; Waterhouse RN; Seibyl JP; Marek KL
JAMA Neurol; 2014 Dec; 71(12):1520-8. PubMed ID: 25322077
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of miR-9* in the peripheral leukocytes of Huntington's disease patients.
Chang KH; Wu YR; Chen CM
Orphanet J Rare Dis; 2017 Dec; 12(1):185. PubMed ID: 29258536
[TBL] [Abstract][Full Text] [Related]
12. Retinal thickness as a biomarker of cognitive impairment in manifest Huntington's disease.
Murueta-Goyena A; Del Pino R; Acera M; Teijeira-Portas S; Romero D; Ayala U; Fernández-Valle T; Tijero B; Gabilondo I; Gómez Esteban JC
J Neurol; 2023 Aug; 270(8):3821-3829. PubMed ID: 37079031
[TBL] [Abstract][Full Text] [Related]
13. Association of status redox with demographic, clinical and imaging parameters in patients with Huntington's disease.
Peña-Sánchez M; Riverón-Forment G; Zaldívar-Vaillant T; Soto-Lavastida A; Borrero-Sánchez J; Lara-Fernández G; Esteban-Hernández EM; Hernández-Díaz Z; González-Quevedo A; Fernández-Almirall I; Pérez-López C; Castillo-Casañas Y; Martínez-Bonne O; Cabrera-Rivero A; Valdés-Ramos L; Guerra-Badía R; Fernández-Carriera R; Menéndez-Sainz MC; González-García S
Clin Biochem; 2015 Dec; 48(18):1258-63. PubMed ID: 26210848
[TBL] [Abstract][Full Text] [Related]
14. Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease.
Leoni V; Mariotti C; Tabrizi SJ; Valenza M; Wild EJ; Henley SM; Hobbs NZ; Mandelli ML; Grisoli M; Björkhem I; Cattaneo E; Di Donato S
Brain; 2008 Nov; 131(Pt 11):2851-9. PubMed ID: 18772220
[TBL] [Abstract][Full Text] [Related]
15. Alterations in Cerebrospinal Fluid Urea Occur in Late Manifest Huntington's Disease.
Pfalzer AC; Shiino S; Silverman J; Codreanu SG; Sherrod SD; McLean JA; Claassen DO
J Huntingtons Dis; 2024; 13(1):103-111. PubMed ID: 38461512
[TBL] [Abstract][Full Text] [Related]
16. High Levels of Mutant Huntingtin Protein in Tear Fluid From Huntington's Disease Gene Expansion Carriers.
Gijs M; Jorna N; Datson N; Beekman C; Dansokho C; Weiss A; Linden DEJ; Oosterloo M
J Mov Disord; 2024 Apr; 17(2):181-188. PubMed ID: 38379425
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial respiratory chain complex activity and bioenergetic alterations in human platelets derived from pre-symptomatic and symptomatic Huntington's disease carriers.
Silva AC; Almeida S; Laço M; Duarte AI; Domingues J; Oliveira CR; Januário C; Rego AC
Mitochondrion; 2013 Nov; 13(6):801-9. PubMed ID: 23707479
[TBL] [Abstract][Full Text] [Related]
18. Biological and clinical manifestations of juvenile Huntington's disease: a retrospective analysis.
Fusilli C; Migliore S; Mazza T; Consoli F; De Luca A; Barbagallo G; Ciammola A; Gatto EM; Cesarini M; Etcheverry JL; Parisi V; Al-Oraimi M; Al-Harrasi S; Al-Salmi Q; Marano M; Vonsattel JG; Sabatini U; Landwehrmeyer GB; Squitieri F
Lancet Neurol; 2018 Nov; 17(11):986-993. PubMed ID: 30243861
[TBL] [Abstract][Full Text] [Related]
19. Mutant Huntingtin Inhibits αB-Crystallin Expression and Impairs Exosome Secretion from Astrocytes.
Hong Y; Zhao T; Li XJ; Li S
J Neurosci; 2017 Sep; 37(39):9550-9563. PubMed ID: 28893927
[TBL] [Abstract][Full Text] [Related]
20. Mutant Huntingtin Impairs BDNF Release from Astrocytes by Disrupting Conversion of Rab3a-GTP into Rab3a-GDP.
Hong Y; Zhao T; Li XJ; Li S
J Neurosci; 2016 Aug; 36(34):8790-801. PubMed ID: 27559163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
